Cross sectional study examines serum fibrinogen levels' association with disease severity in polymyalgia rheumatica, suggesting potential clinical implications.
Key Points
Raised serum fibrinogen levels significantly correlate with greater disease severity in polymyalgia rheumatica patients.
Among 132 patients, 45% exhibited elevated fibrinogen levels, indicating a potential biomarker for severity.
The analysis was conducted over a duration from July 2019 to February 2020 in a military hospital setting.
Findings suggest that increased fibrinogen could help predict severe forms of polymyalgia rheumatica, warranting further consideration.